OverviewChartTechnicalNewsTraderScreen

Psychemedics Corporation/  US7443752057  /

NASDAQ
2024-06-21  10:00:00 PM Chg. +0.0600 Volume Bid10:09:54 AM Ask10:09:54 AM High Low
2.3500USD +2.62% 2,090
Turnover: 3,708.0300		 0.9400Bid Size: 200 3.7300Ask Size: 100 2.3500 2.2600
GlobeNewswire 06-21 Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
GlobeNewswire 05-14 Psychemedics Corporation Reports First Quarter 2024 Financial Results
GlobeNewswire 03-28 Psychemedics Corporation Reports 2023 Financial Results
GlobeNewswire 03-21 Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
GlobeNewswire 01-02 Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
GlobeNewswire 2023-11-27 Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
GlobeNewswire 2023-11-09 Psychemedics Corporation Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-27 Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
GlobeNewswire 2023-09-21 Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
GlobeNewswire 2023-08-18 Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2022-03-22 Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retireme...
GlobeNewswire 2021-12-10 Psychemedics Corporation Declares Cash Dividend
GlobeNewswire 2021-11-12 Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Qua...
GlobeNewswire 2021-08-10 Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
GlobeNewswire 2021-05-10 Psychemedics Corporation Reports First Quarter 2021 Financial Results
GlobeNewswire 2021-03-23 Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire 2021-03-17 Robyn C. Davis Joins Psychemedics Board of Directors
GlobeNewswire 2021-01-26 Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller
GlobeNewswire 2020-12-17 Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
GlobeNewswire 2020-11-09 Psychemedics Announces Third Quarter Results
GlobeNewswire 2020-08-12 Psychemedics Announces Second Quarter Results
GlobeNewswire 2020-05-13 Psychemedics Announces First Quarter Results
GlobeNewswire 2020-05-05 Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine
GlobeNewswire 2020-04-29 Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA
GlobeNewswire 2020-04-28 Psychemedics Corporation to Webcast 2020 Annual Meeting of Stockholders